Back to search

University of South Florida

Marigold-Silver Nanoparticles (AgNPs) Complex: Characterization, Therapeutic Potential, and Future Approaches for Lung Injury via Antioxidant and Anti-Inflammatory Effects

Abstract

dc:description

Chronic respiratory diseases (CRDs) and other lung conditions are a key cause of the problems facing global health, as they greatly increase morbidity, death, and the financial burden. In order to achieve the third Sustainable Development Goal of the United Nations, which is to reduce premature mortality from non-communicable illnesses by one-third by 2030, updated epidemiological statistics are crucial for directing prevention, control, and treatment measures. One of the major reasons of illness and death globally is chronic obstructive pulmonary disease (COPD). Lung damage and the emergence of CRDs, such as asthma, emphysema, COPD, and other respiratory disorders, are largely caused by inflammation and oxidative stress. There is an urgent need for innovative approaches because traditional therapeutic approaches are frequently constrained, ineffective, and have adverse effects.Examining marigold (Calendula officinalis) conjugated silver nanoparticles (Marigold-AgNPs) as a possible lung damage treatment method is the aim of this study. During the green, plant-mediated synthesis of the nanoparticles, marigold extract was utilized as a stabilizing and reducing agent, incorporating advantageous phytochemicals directly into the nanoparticle structure. Nanoparticle formation, size, shape, surface charge, and colloidal stability were all confirmed by thorough characterization using Ultraviolet-Visible spectroscopy Plate Reader, Transmission Electron Microscopy (TEM), and Zeta Potential Analysis. Marigold-AgNPs should be well absorbed by lung cells, lowering inflammation and oxidative stress while promoting cell health. It is anticipated that this versatile nanotechnology platform will become a safe and biocompatible approach to treating lung disorders, including chronic respiratory conditions. Preclinical in vivo studies, targeted delivery system optimization, long-term safety assessments, and translational research should be given top priority in future studies in order to progress therapeutic clinical applications. In general, this strategy seeks to combine nanotechnology with bioactive compounds that are naturally occurring in order to create novel, long-lasting, and efficient treatments for lung conditions all over the world.

Degree

thesis:*
Name thesis:degree_name
Master of Science (M.S.)
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Pharmacy
Grantor
University of South Florida
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kaur, Navdeep
Contributors dc:contributor
  • Diane S. Allen-Gipson, Ph.D.
  • Bill J. Baker, Ph.D.
  • Mark Kindy, Ph.D.

Subjects

dc:subject × 8

Rights

Language dc:language
EN-US

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/11058

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Kaur, Navdeep. Marigold-Silver Nanoparticles (AgNPs) Complex: Characterization, Therapeutic Potential, and Future Approaches for Lung Injury via Antioxidant and Anti-Inflammatory Effects. Thesis thesis, University of South Florida, 2025. https://digitalcommons.usf.edu/etd/11058